Compare VIV & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIV | BNTX |
|---|---|---|
| Founded | 1973 | 2008 |
| Country | Brazil | Germany |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6B | 24.2B |
| IPO Year | 1998 | 2019 |
| Metric | VIV | BNTX |
|---|---|---|
| Price | $15.69 | $101.61 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | $14.80 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 876.0K | 801.0K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.22 | N/A |
| Revenue Next Year | $5.52 | $3.37 |
| P/E Ratio | $22.12 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.51 | $79.81 |
| 52 Week High | $17.26 | $124.00 |
| Indicator | VIV | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 43.12 | 54.77 |
| Support Level | $15.17 | $99.08 |
| Resistance Level | $16.47 | $113.02 |
| Average True Range (ATR) | 0.33 | 3.69 |
| MACD | -0.11 | 0.62 |
| Stochastic Oscillator | 14.85 | 51.23 |
Telefonica Brasil, known as Vivo, is the largest wireless carrier in Brazil with 102 million customers, which is equal to about 39% market share. The firm is strongest in the postpaid business, where it has 68 million customers, or about 41% share of this market. Wireless services and equipment contribute about 70% of total revenue. Vivo is the incumbent fixed-line telephone operator in Sao Paulo state and also owns an extensive fiber network across the country. The firm provides internet access to 8 million households on this network. The firm also sells pay-TV and phone services to its fixed-line customers. Finally, corporate data and IT services, including cloud computing support, contribute about 9% of total revenue.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.